Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 2 | 2023 | 24 | 1.520 |
Why?
|
| Mouth Neoplasms | 3 | 2025 | 31 | 1.260 |
Why?
|
| Nose Neoplasms | 2 | 2017 | 17 | 1.090 |
Why?
|
| Head and Neck Neoplasms | 2 | 2024 | 148 | 0.770 |
Why?
|
| Skull Base | 1 | 2021 | 13 | 0.730 |
Why?
|
| Neck | 1 | 2020 | 46 | 0.690 |
Why?
|
| Head | 1 | 2020 | 53 | 0.680 |
Why?
|
| Preoperative Care | 1 | 2021 | 180 | 0.680 |
Why?
|
| Robotic Surgical Procedures | 1 | 2020 | 115 | 0.590 |
Why?
|
| Software | 1 | 2021 | 366 | 0.580 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2017 | 15 | 0.580 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 2017 | 2 | 0.570 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 651 | 0.560 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 451 | 0.510 |
Why?
|
| Algorithms | 1 | 2021 | 974 | 0.500 |
Why?
|
| Internship and Residency | 1 | 2023 | 746 | 0.490 |
Why?
|
| Melanoma | 1 | 2016 | 329 | 0.410 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2025 | 237 | 0.410 |
Why?
|
| Paranasal Sinuses | 2 | 2021 | 7 | 0.350 |
Why?
|
| Endoscopy | 2 | 2021 | 98 | 0.310 |
Why?
|
| Sinusitis | 2 | 2019 | 28 | 0.300 |
Why?
|
| Humans | 18 | 2025 | 59387 | 0.260 |
Why?
|
| Male | 13 | 2025 | 27751 | 0.250 |
Why?
|
| Female | 13 | 2025 | 30728 | 0.240 |
Why?
|
| Margins of Excision | 1 | 2025 | 24 | 0.240 |
Why?
|
| Databases, Factual | 4 | 2025 | 814 | 0.230 |
Why?
|
| Free Tissue Flaps | 1 | 2024 | 2 | 0.230 |
Why?
|
| Osteoradionecrosis | 1 | 2024 | 3 | 0.230 |
Why?
|
| Oral Health | 1 | 2025 | 62 | 0.220 |
Why?
|
| Adult | 9 | 2025 | 15687 | 0.200 |
Why?
|
| Salvage Therapy | 1 | 2022 | 72 | 0.200 |
Why?
|
| Middle Aged | 10 | 2025 | 16320 | 0.200 |
Why?
|
| Adolescent | 4 | 2021 | 5835 | 0.190 |
Why?
|
| Aged | 8 | 2025 | 13415 | 0.190 |
Why?
|
| Survival Rate | 3 | 2018 | 802 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 300 | 0.170 |
Why?
|
| Neurosurgical Procedures | 1 | 2021 | 95 | 0.170 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 31 | 0.170 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2018 | 58 | 0.170 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 317 | 0.170 |
Why?
|
| Robotics | 1 | 2020 | 69 | 0.160 |
Why?
|
| Young Adult | 2 | 2021 | 4272 | 0.160 |
Why?
|
| Retrospective Studies | 5 | 2024 | 6072 | 0.160 |
Why?
|
| Nasal Polyps | 1 | 2019 | 9 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2024 | 5284 | 0.160 |
Why?
|
| United States | 5 | 2025 | 7425 | 0.160 |
Why?
|
| Doxycycline | 1 | 2019 | 42 | 0.160 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 5124 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 2379 | 0.150 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2017 | 3 | 0.150 |
Why?
|
| Intracranial Pressure | 1 | 2017 | 19 | 0.140 |
Why?
|
| Tampons, Surgical | 1 | 2017 | 1 | 0.140 |
Why?
|
| Nasal Cavity | 1 | 2017 | 10 | 0.140 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 58 | 0.140 |
Why?
|
| Meningioma | 1 | 2018 | 59 | 0.140 |
Why?
|
| Rhinitis | 1 | 2017 | 22 | 0.140 |
Why?
|
| Pharynx | 1 | 2017 | 21 | 0.140 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2017 | 5 | 0.140 |
Why?
|
| Rhabdomyosarcoma | 1 | 2017 | 16 | 0.140 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 102 | 0.140 |
Why?
|
| Maxillary Sinus Neoplasms | 1 | 2016 | 2 | 0.140 |
Why?
|
| Carcinoma | 1 | 2016 | 116 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2024 | 1204 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2016 | 555 | 0.120 |
Why?
|
| Thrombopoiesis | 1 | 2014 | 1 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2017 | 405 | 0.110 |
Why?
|
| Erythropoiesis | 1 | 2014 | 35 | 0.110 |
Why?
|
| Prognosis | 1 | 2017 | 1600 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2014 | 152 | 0.090 |
Why?
|
| Incidence | 2 | 2025 | 1239 | 0.090 |
Why?
|
| Child | 1 | 2020 | 4186 | 0.090 |
Why?
|
| Obesity | 1 | 2017 | 1166 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1023 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 354 | 0.070 |
Why?
|
| Periodontal Diseases | 1 | 2025 | 17 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2019 | 717 | 0.060 |
Why?
|
| Microsurgery | 1 | 2024 | 51 | 0.060 |
Why?
|
| Sex Factors | 1 | 2025 | 935 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2025 | 1051 | 0.050 |
Why?
|
| Logistic Models | 1 | 2025 | 1234 | 0.050 |
Why?
|
| Cadaver | 1 | 2021 | 110 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 330 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 2019 | 32 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2025 | 1925 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 356 | 0.040 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2017 | 14 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 43 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 452 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2019 | 715 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 396 | 0.030 |
Why?
|
| Nausea | 1 | 2017 | 110 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2016 | 49 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 141 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 742 | 0.030 |
Why?
|
| Risk Factors | 1 | 2025 | 4986 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 1507 | 0.030 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2014 | 1 | 0.030 |
Why?
|
| Erythroblasts | 1 | 2014 | 15 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 2014 | 18 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1479 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2014 | 170 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 103 | 0.030 |
Why?
|
| Species Specificity | 1 | 2014 | 329 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 417 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2014 | 259 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 651 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 590 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 3231 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 1471 | 0.020 |
Why?
|
| Mice | 1 | 2014 | 10295 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 19651 | 0.010 |
Why?
|